Multiple system atrophy: A prototypical synucleinopathy for disease-modifying therapeutic strategies-Reference-Cited by-同舟云学术

Multiple system atrophy: A prototypical synucleinopathy for disease-modifying therapeutic strategies

Published:2014-07 Issue: Volume:67 Page:133-139
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Fernagut Pierre-Olivier,Dehay Benjamin,Maillard Aline,Bezard Erwan,Perez Paul,Traon Anne Pavy-Le,Rascol Olivier,Foubert-Samier Alexandra,Tison François,Meissner Wassilios G.

Publisher

Elsevier BV

Subject

Neurology

Reference89 articles.

1. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?;Ahlskog;Neurology,2010

2. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy;Al-Chalabi;PLoS One,2009

3. Alpha-synuclein mRNA expression in oligodendrocytes in MSA;Asi;Glia,2014

4. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study;Bensimon;Brain,2009

5. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease;Campbell;J. Neurochem.,2001

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipids and α-Synuclein: adding further variables to the equation;Frontiers in Molecular Biosciences;2024-08-12

2. Surface-Based Neuroimaging Pattern of Multiple System Atrophy;Academic Radiology;2023-12

3. GRK2‐Targeted Knockdown as Therapy for Multiple System Atrophy;Movement Disorders;2023-04-24

4. Diagnostic utility of GDF15 in neurodegenerative diseases: A systematic review and meta‐analysis;Brain and Behavior;2022-01-24

5. A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy;Movement Disorders;2020-09-03